Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

NCRI 2010 /
Translational science centre

7th - 10th Nov 2010

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 28.12.10
Views: 5382
Rating:

Prof Nic Jones - MCRC and Paterson Institute, Manchester, UK

Prof Nic Jones speaks about the translational research carried out at the Paterson Institute and how the development of the new patient treatment centre at The Christie in Manchester will increase the capacity for clinical trials threefold. The early clinical trials are closely linked with translational laboratory based biomarker research including the identification and validation of new biomarkers, the development of new biomarker assays and the biobank. Prof Jones explains how the design of the new patient treatment centre will benefit patients and discusses the drug discovery centre in Manchester. This new drug discovery centre, together with the increased capacity of the imaging centre, clinical pharmacology and early phase clinical trials will help build a more comprehensive multidiscipline approach to cancer care. Prof Jones concludes by discussing research planned at The Christie into resistance to radiotherapy and combination trials of radiotherapy and radiosensitiser drugs.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation